Skip to main content
. 2014 Nov 1;6(6):1598–1607. doi: 10.4161/mabs.36089

Figure 4.

Figure 4.

HUVEC cell assay (trans-signaling). Results from an analysis of the ability of affibody variants ZIL-6_4, ZIL-6_8, ZIL-6_12, ZIL-6_13 and ZIL-6_15, expressed as Z-ABD fusion proteins, or the mAb tocilizumab, to block the IL-6 triggered secretion of MCP-1 from HUVEC cells.